Who invested in Granite Bio?
Granite Bio's investors include Forbion Capital Partners, Sanofi, Versant Ventures and Novartis. Forbion Capital Partners led its latest round.
United States · Series B startup
One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Granite Bio and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$70Mraised across 1 round since 2025, from 1 source
Reported by Silicon Canals
Granite Bio's investors include Forbion Capital Partners, Sanofi, Versant Ventures and Novartis. Forbion Capital Partners led its latest round.
Granite Bio has raised $70M across 1 round since 2025.
Granite Bio's most recent round was a Series B of $70M in Apr 2025, led by Forbion Capital Partners.
Its most recent round, $70M in Apr 2025, is also its largest on record.
Granite Bio's first round on record, in Apr 2025, was backed by Forbion Capital Partners, Sanofi and Versant Ventures and 1 others.
Granite Bio's latest named round is a Series B, in Apr 2025.
Granite Bio is based in the United States.
Forbion Capital Partners led the Series B in 2025.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.